Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBN tablets in amyotrophic lateral sclerosis
CTR20202126Phase 2Completed
- Sponsor
- Guangzhou Magpie Pharmaceutical
- Start
- Oct 2020
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tetramethylpyrazine nitrone in amyotrophic lateral sclerosis (ALS), sponsored by Guangzhou Magpie Pharmaceutical. Started Oct 2020; status: completed.
02
Drugs
tetramethylpyrazine nitrone
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on CTR20202126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202126.